CONTACT
Group Companies
MEDIA STORIES
02-Mar-2021
Biocon Biologics, Viatris get CHMP nod for Abevmy
02-Mar-2021
Biocon Biologics to partner with International Diabetes Federation
16-Feb-2021
Biocon arm, CHAI in pact on affordable cancer therapies
04-Feb-2021
Expect Accelerated Growth from Next Fiscal, Says Kiran Mazumdar-Shaw
25-Jan-2021
Biocon says may have to delay biologics biz IPO
25-Jan-2020
PANDEMIC PAIN Biocon Chairperson Kiran Mazumdar-Shaw says the Covid impact on business across the value chain has been larger than expected p2
25-Jan-2020
Biocon Biologics Receives USD 150 Million Capital Injection from Goldman Sachs
08-Nov-2020
India-based company brings affordable insulin to 2 PH towns
23-Oct-2020
Will Biocon’s COVID-19 anti-inflammatory succeed where IL-6 blockers have failed?
01-Aug-2020
India’s Biocon secures approval to use drug on coronavirus patients
11-July-2020
Biosimilar drugs can help us reach $1 billion target soon
16-Jun-2020
Kiran Mazumdar-Shaw named EY World Entrepreneur of 2020
06-Jun-2020
Covid provides larger opportunity to shape the biosimilar landscape
19-May-2020
Will invest Rs2,000 crore in small molecules in 3-4 years
16-May-2020
Biocon wins patent case against Sanofi
12-Mar-2020
Biocon’s cancer biosimilar gets US FDA acceptance for review
10-Mar-2020
Biocon chief is EY entrepreneur for 2019
22-Feb-2020
Biocon Biologics Eyes $200M. Plans IPO in 2 Yrs: Mazumdar-Shaw
27-Jan-2020
Biocon Q3 PBT up 9%
24-Jan-2020
Biocon optimistic about hitting $1 billion in revenue by FY22 on back of new launches
08-Jan-2020
Biocon, partner Mylan launch oncology biosimilar trastuzumab in US
11-Dec-2019
USFDA nod to Biocon’s new Bengaluru unit
28-Nov-2019
Biocon, Mylan get nod for pegfilgrastim drug
28-Nov-2019
Indian company makes it to top 10 best employers in biotech category
30-Oct-2019
Insulin at ₹7 will be a gamechanger for us
26-Oct-2019
Life-enabling product like insulin should be made affordable: Shaw
28-Sep-2019
Biocon plans to halve insulin prices
27-Sep-2019
Biocon sets $1 billion target for biologics business
25-Oct-2019
Biocon subsidiary acquires Pfizer’s R&D facility in Chennai
25-Sep-2019
Blueprint for a Healthy India
25-Sep-2019
Ramp-up of biosimilar portfolio to boost Biocon
22-Aug-2019
Our aim is to be a global leader in biosimilars biz: Biocon Biologics CEO
30-Jul-2019
Biocon’s net rises 86%, revenue 25%
26-Jul-2019
Biocon net profit grows 72%
25-Jul-2019
Biosimilars, research key drivers for Biocon
18-Jun-2019
Trastuzumab’s US launch will be a big opportunity for Biocon-Mylan: Shaw
18-Jun-2019
Biocon’s Bengaluru biologics units get European agency nod
15-Jun-2019